Ameriprise Financial Inc Y M Abs Therapeutics, Inc. Transaction History

Ameriprise Financial Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$4.86 - $7.23 $51,516 - $76,638	10,600 Added 34.0%	41,781 $227,000
Q2 2023 Aug 14, 2023	BUY	$5.68 - $10.34 $177,108 - $322,411	31,181 New	31,181 $211,000
Q4 2022 Feb 14, 2023	SELL	$3.0 - $15.17 $3,318 - $16,778	-1,106 Reduced 1.64%	66,392 $323,000
Q3 2022 Nov 14, 2022	SELL	$13.96 - $19.67 $28,422 - $40,048	-2,036 Reduced 2.93%	67,498 $973,000
Q2 2022 Aug 15, 2022	BUY	$8.22 - $15.13 $571,569 - $1.05 Million	69,534 New	69,534 $1.05 Million

106

24.5M

40.3K

400

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $356M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.